Speakers: Dr. Jürgen Braunger of Boehringer Ingelheim Pharma, Dr. Timothy Radstake of AbbVie & Dr. Christopher D. Whelan of Biogen
The right drug targets for the right patient – Using biomarkers to solve challenges in drug development
Dec 3, 2021 9:53:45 AM / by Olink posted in Multiomics, Drug discovery & development, Personalized medicine
Maximizing the power of proteomic clinical trial profiling for better actionable insights - a new collaborative initiative from the SCALLOP consortium
Aug 12, 2021 10:31:53 AM / by Olink posted in Multiomics, Clinical research, Drug discovery & development, Proteogenomics
Speakers: Anders Mälarstig, Direct of Target science at Pfizer
Biomarker Discovery and Custom Panel Development for Multiple Sclerosis Disease Assessments Utilizing the Olink Platform
Aug 12, 2021 10:29:39 AM / by Olink posted in Neurology, Drug discovery & development, Multiple Sclerosis
Speakers: Ferhan Qureshi, Vice President Biomarker Product Development at Octave Bioscience
Uncovering novel protein biomarkers in drug discovery and development: Targeting disease diagnosis and drug response monitoring
Aug 12, 2021 10:23:14 AM / by Olink posted in Neurology, Drug discovery & development
Speakers: Christopher Whelan, Senior scientist in the Translational Biology Research Group at Biogen & Simina Ticau, Senior scientist at Alnylam Pharmaceuticals